mHealth to Early Detect Exacerbation for Older People With Heart Failure

NCT ID: NCT02506738

Last Updated: 2015-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-08-31

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study was to demonstrate the effectiveness of telemonitoring functional status and vital signs to early detect heart failure exacerbation, and to minimize readmissions and length of hospitalisations.

Patients over 75 with heart failure were included after a hospitalisation due to heart failure exacerbation. Patients were assigned randomly into intervention or control. The intervention group comprised 47 patients who were assessed through telemonitoring, while 40 followed traditional clinical pathways.

Patients were followed-up for 3 months after discharge, collecting emergency visits and readmissions due to a new heart failure exacerbation. Those patients in the intervention group used a commercial telemedicine system: Careline H@me, which was provided by the company SALUDNOVA. They system was personalized by adding the functional status monitoring capabilities. Thus, the system collected vital signs (i.e. blood pressure, heart rate, respiratory rate, oxygen saturation, glucose, and weight); symptoms of decompensated heart failure (i.e. dyspnoea and orthopnoea); and functional status (i.e. part of the Short Physical Performance Battery, SPPB) and a brief questionnaire (i.e. Do you have the medication?) every 48 hours.

Two staff geriatricians at the Hospital Universitario de Getafe accessed, during working days, a secured dedicated web-portal to assess the progression of their patients, evaluated through the monitored variables and the self reported symptoms. They reacted to the data, if needed, making a phone call or visiting the patient. Besides, patients could contact the geriatricians or attending the emergency room as usually.

After completion, we analysed the results. First, we carried out a descriptive analysis of the data. Later, we analysed the effects of the intervention with telemedicine and the predictive values of the different measured variables through logistic regressions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patient registries were carried out in two different Databases: one included general information on patients and epidemiological data. The other database stored the monitored data obtained every 48 hours.

Quality assurance and source data verification was achieved by retrieving general information on patients from the Hospital Electronic Medical Record. Moreover epidemiological information was assessed by the Principal Investigator who removed outlier values and assessed the occurrence of sharp changes in temporal series (e.g. changes \>0.5Kg in two days).

Patients were recruited at the acute unit of the Geriatrics Service. When they were admitted due a heart failure exacerbation a trained nurse performed the initial assess. If the patient was suitable, a geriatrician explained to him /her the study and if the patient accepted we was asked to sign the informed consent. Then he was assigned randomly to a group. For those in the intervention group, they were trained by the geriatrician and the nurse on how to perform the measurements in the mobile phone. For those in the control group, the staff recorded the baseline characteristics, and during the follow-up the emergency visits, readmissions and death was recorded. These latter variables were also recorded in the patients of the intervention group.

The data dictionary included variables identifying patients and others describing their status and evolution:

* Oxygen saturation, measured as an integer (80-100)
* Heart rate, measured in beats/minute (0-200)
* Diastolic blood, measured in mmHg (0-100)
* Systolic blood pressure, measured in mmHg (0-100)
* Respiratory rate, measured in breaths/minute (0-100)
* Skin temperature, measured in Celsius
* Weight, measured in kg
* Glucose, measured in mg/dl (0-500)
* Short Physical Performance Battery, time to walk for 4.3 meters, measured in seconds (0-100)
* Short Physical Performance Battery, gait speed for 4.3 meters, measured in decimal meters/second (0-1)
* Short Physical Performance Battery, chair stand test once, measured in seconds (0-100)
* Symptom question Q1: Do you feel worse than the last time?, measured as a Boolean variable (YES/NO)
* Symptom question Q2: Do you feel worse than the day of the hospital discharge?, measured as a Boolean variable (YES/NO)
* Symptom question Q3: Do you feel shorten of breath?, measured as a categorical variable (effort/DLA/at rest)
* Symptom question Q4: Do you feel your legs swollen? ?, measured as a Boolean variable (YES/NO)
* Symptom question Q5: Have you woken up during the night feeling fatigue? ?, measured as a Boolean variable (YES/NO)
* Symptom question Q6: Have you needed more pillows to sleep than last time? ?, measured as a Boolean variable (YES/NO)
* Symptom question Q7: Have you taken all your drugs? ?, measured as a Boolean variable (YES/NO)
* Symptom question Q8: Have you followed the food and drinks indications of your physician?, measured as a Boolean variable (YES/NO) Sample size was calculated to reduce readmission rate by 10% in 3 months time. Having a significant level of 0.05. Sample: 50-60 per group. With the first 20 patients included, sample size was recalculated, only 40 were needed in each group. However, we included more patients in the intervention (up to 50) to face drops, only 3 dropped the study, so we obtained data from 47 in the intervention group.

Missing data were excluded from the analysis, the registry was excluded. If a patient registered more than one measurement for the same expected data, the latest remained, and the rest was deleted.

Statistical analysis:

First, we carried out a descriptive analysis of the data. Later, we analysed the effects of the intervention with telemedicine and the predictive values of the different measured variables through logistic regressions.

Descriptive data are presented as median values (IQR). Baseline characteristics between control and intervention groups were compared using non-parametric tests (Mann-Whitney).

In order to determine the effects of the intervention, the analysis was divided in two parts. First, a logistic regression model was fitted to determine if the patient monitorization (yes/no) significantly predict worsening using age and sex as covariates. Then, a new variable, hospitalization length of stay, was created with the length of stay for any readmission in each group to assess whether the use of telemonitoring affected the length of hospitalisation. Both control and intervention groups were compared using Mann-Whitney.

Finally, in the intervention group, the same logistic regression model was fitted to determine the factors that significantly predict worsening.

All analyses were made with the Statistical Package R for windows (Vienna, Austria) (http://www.r-project.org), version 3.1.1. P-value was set at level \<0.05.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention using mHealth

Patients in the intervention used at home a mobile system to monitor their clinical and health status.

Group Type ACTIVE_COMPARATOR

Intervention using mHealth

Intervention Type DEVICE

Patients in the intervention used at home a mobile system to monitor their clinical and health status.

Control

Patients in the control group received the usual care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention using mHealth

Patients in the intervention used at home a mobile system to monitor their clinical and health status.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients admitted at the acute care unit at the Hospital Universitario de Getafe who are diagnosed with Heart Failure as primary cause for admission.

Exclusion Criteria

* Moderate/severe cognitive impairment (MMSE\<23)
* Visual/auditory deficits, communication problems
* Moderate/severe non-reversible functional impairment (Barthel\<60)
* To be institutionalized
* To be discharged to a Functional Rehabilitation Hospital
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SALUDNOVA SOLUTION S.L

UNKNOWN

Sponsor Role collaborator

Instituto de Salud Carlos III

OTHER_GOV

Sponsor Role collaborator

Hospital Universitario Getafe

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI09/91070

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CEIC-09/37

Identifier Type: OTHER

Identifier Source: secondary_id

HUGetafe

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mobile App for Heart Failure
NCT05668000 COMPLETED NA
Mobile Integrated Health in Heart Failure
NCT04662541 ACTIVE_NOT_RECRUITING NA